G3BP1 expression gradually increased in tissue samples of benign to primary PCa tumors and was likely most abundant in CRPC (Fig. 3c; p < 0.001, χ2 test) suggesting that G3BP1 overexpression is associated with more aggressive disease across the clinical spectrum of prostate cancer. Here, G3BP1 is linked to posterior cortical atrophy.